Radiotheranostics Market By Radioisotope (Lutetium-177, Gallium-68, Iodine-131, Actinium-225, Others), By Application (Oncology, Cardiology, Neurology, Others.), By End-user (Hospitals, Diagnostic Imaging Centers, Cancer Research Institutes, Specialty Clinics, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

Published Date: Jun 2025 | Report ID: MI2969 | 219 Pages

Report Summary Table of Contents Segmentation FAQ Request Free Sample Report

Report Coverage:

By Radioisotope

  • Lutetium-177
  • Gallium-68
  • Iodine-131
  • Actinium-225
  • Others

By Application

  • Oncology
  • Cardiology
  • Neurology
  • Others

By End-user

  • Hospitals
  • Diagnostic Imaging Centres
  • Cancer Research Institutes
  • Specialty Clinics
  • Others

By Region

North America

  • U.S.
  • Canada

Europe

  • U.K.
  • France
  • Germany
  • Italy
  • Spain
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest of Asia Pacific

Latin America

  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America

Middle East & Africa

  • GCC Countries
  • South Africa
  • Rest of the Middle East & Africa

List of Companies:

  • Novartis AG
  • Telix Pharmaceuticals Limited
  • Curium
  • Cardinal Health, Inc.
  • GE HealthCare
  • Lantheus Holdings, Inc.
  • ITM Isotope Technologies Munich SE
  • Eckert & Ziegler Strahlen- und Medizintechnik AG
  • Jubilant Radiopharma
  • Bayer AG
  • Theragnostics Ltd
  • NorthStar Medical Radioisotopes, LLC
  • Advanced Accelerator Applications S.A.
  • Bracco Imaging S.p.A.
  • Alpha Tau Medical Ltd.

Maximize your value and knowledge with our 5 Reports-in-1 Bundle - over 40% off!

Our analysts are ready to help you immediately.

Request Bundle Pricing